サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：止血帯の世界市場-2023-2030
市場調査レポート
商品コード
1217638

止血帯の世界市場-2023-2030

Global Tourniquet Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
止血帯の世界市場-2023-2030
出版日: 2023年02月14日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場の概要

止血帯の世界市場規模は、2021年に3億9,085万米ドル、2029年には6億7,821万米ドルに達すると推定され、予測期間（2022～2029年）のCAGRは7.9％で成長するとされています。

止血帯の使用は、整形外科や形成外科の手術でおなじみの方法です。血流を極限まで遮断し、無血の術野を作り、周術期の出血を抑える圧縮器具です。また、局所麻酔薬の中心への広がりを抑制する静脈内局所麻酔（ビアーズブロック）にも使用されています。

市場力学

整形外科手術や形成外科手術の増加、交通事故による外傷の増加などが、予測期間中の止血帯市場の成長を牽引しています。

止血帯は、世界中の四肢の手術で定期的かつ安全に利用されています。したがって、整形外科や形成外科の手術の増加は、世界の止血帯市場の成長を後押しします。例えば、欧州連合2020年統計によると、2020年にドイツでは人口10万人あたり約294回、フィンランド、オーストリア、オランダ（2019年データ）、デンマークでは人口10万人あたり250～269回、これらはデータが判明しているEU加盟国の中で最も一般性が高まった、膝置換は股関節置換よりもEU加盟国の間でばらつきが大きいです。さらに、マルタを除いて、膝関節全置換術は股関節全置換術よりも一般的ではありませんでした。例えば、2020年には、フィンランドとドイツで人口10万人あたり200件以上の人工膝関節置換術が行われています。

また、American Joint Replacement Registry 2021によると、2021年にはデータを提示した1150以上の施設から240万件以上の股関節・膝関節手術が行われ、2020年と比較して総手術件数は18.3％増加しました。同様に、米国形成外科学会によると、2020年には230万件の美容外科手術と1320万件の美容低侵襲手術からなる約1560万件の美容整形手術と、約680万件の再建手術が行われたとのことです。さらに、交通事故の増加も止血帯の世界市場の成長に寄与しています。例えば、世界保健機関の統計によると、およそ130万人が毎年交通事故による緊急事態で死亡しています。また、約2,000万人から5,000万人が非致死性の傷害に苦しんでいます。さらに、CDCは、2020年に手術を必要とする非致死的傷害の統計を提供しており、約2,885,545の外来症例があります。上記のデータから、世界中で整形外科手術、形成外科手術、交通事故の発生件数が増加していることが、世界の止血帯市場の成長を後押ししています。

止血帯による負傷の発生は、世界の止血帯市場の成長を抑制します。

しかし、手術における止血帯の意味合いは、しびれ、麻痺、筋萎縮を伴う麻痺のため、臨床的な皮膚、筋肉、血管、結合組織、神経損傷の脅威となることです。このうち、低酸素とアシドーシスは、主に組織の虚血と筋損傷を誘発します。さらに、止血帯解除後の灌流は、生理的な血圧上昇、体温低下、酸素ストレスをもたらし、毒性代謝物の全身循環への再還流につながります。このような止血帯の使用に伴う合併症が、予測期間中の世界市場の成長を抑制しています。

COVID-19の影響

COVID-19の流行期間中、社交や社会的な集まりの制約により、交通事故による死傷者、スポーツ障害、外科的介入を必要とするその他の医療疾患の数が減り、世界的に市場成長の減少を余儀なくされました。例えば、国際美容整形外科学会によると、パンデミックの間、整形外科手術は減少しました。約10.9%、約78%の外科医が一時的な診療所の閉鎖を経験しました。さらに、国立保健医療科学院によると、パンデミックの最初の年に整形外科手術が約23%減少しました。その中でも、膝関節形成術の影響が最も大きかっています。人工股関節置換術は約64％減、膝靭帯再建術は約41％減、44％減となり、止血帯の必要性が低くなっています。これらの統計は、止血帯市場がCOVID-19の世界的流行によってマイナスの影響を受けたことを示しています。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 整形外科・形成外科手術の増加
      • 交通事故の増加
    • 抑制要因
      • 止血帯別傷害
    • ビジネスチャンス
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 規制分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み
  • まとめ

第7章 コンポーネント別

  • 止血帯器具
  • 止血帯カフ
    • 空気圧式止血帯カフ
    • 非空気式止血帯カフス

第8章 用途別

  • 上肢の手術
  • 下肢の手術
  • その他

第9章 エンドユーザー別

  • 病院・クリニック
  • 外来手術センター
  • 整形外科クリニック

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク

第12章 企業プロファイル

  • Zimmer Biomet
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Stryker
  • ATMOS MedizinTechnik GmbH & Co. KG
  • VBM
  • DDM
  • Anetic Aid
  • HPM
  • Huifeng Medical
  • DS MAREF
  • Bohus Medical

第13章 DataM

目次
Product Code: DMMD2821

Market Overview

The global tourniquet market size was valued at US$ 390.85 million in 2021 and is estimated to reach US$ 678.21 million by 2029, growing at a CAGR of 7.9% during the forecast period (2022-2029).

Tourniquet use is a familiar approach in orthopedic and plastic surgeries. They are compressive instruments that block blood flow to the extremes to produce a bloodless surgical field and reduce perioperative blood loss. They are also employed for intravenous regional anesthesia (Bier's block) to control the central spread of local anesthetics.

Market Dynamics

The growing number of orthopedic surgeries, plastic surgeries and the increasing incidents of road accident trauma drive the tourniquet Market growth during the forecast period.

Tourniquets are regularly and safely utilized in extremities surgeries throughout the globe. Thus, the increasing number of orthopedic and plastic surgeries boosts global tourniquet market growth. For instance, according to the European Union 2020 statistics, hip replacements were performed about 294 times per 100 000 residents in Germany in 2020 and between 250 and 269 times per 100 000 inhabitants in Finland, Austria, and the Netherlands (2019 data) and Denmark; these were the most elevated commonnesses among the EU Member States for which data are known, knee replacements varied more between the EU Member States than did hip replacements. Furthermore, except for Malta, total knee replacements were less common than hip replacements. For instance, in 2020, more than 200 knee replacements per 100 000 inhabitants were performed in Finland and Germany.

In addition, according to the American Joint Replacement Registry 2021, over 2.4 million hip and knee surgeries from over 1150 institutions that presented data took place in 2021, representing an 18.3% upsurge in total procedural volume compared with that in 2020. Likewise, according to the American Society of Plastic Surgeons, around 15.6 million cosmetic procedures comprised 2.3 million cosmetic surgical procedures and 13.2 million cosmetic minimally-invasive procedures, and about 6.8 million reconstructive procedures were performed in 2020. Besides, the increasing number of road accidents contributes to the growth of the global tourniquet Market. For example, according to statistics from the world health organization, roughly 1.3 million people die yearly from road casualty emergencies. Almost 20-50 million individuals suffer from non-fatal injuries. Moreover, the CDC has supplied statistics of non-fatal injuries needing surgery in 2020, with approximately 2,885,545 ambulatory cases. From the data mentioned above, the rising number of orthopedic surgeries, plastic surgeries and incidents of road accidents worldwide is pushing the global tourniquet market growth.

The incidences of tourniquet injuries will restrain the global tourniquet market growth.

However, the implication of a tourniquet in surgery is the threat of clinical skin, muscle, blood vessels, connective tissue, and nerve damage because of numbness, paresis, or paralysis with muscle atrophy. Among these, hypoxia and acidosis primarily induce tissue ischemia and muscle damage. Furthermore, after releasing the tourniquet, perfusion leads to a physiological elevation in blood pressure, lowered body temperature, and oxygen stress, which is connected to the reentry toxic metabolites back into the systemic circulation. Such complications associated with tourniquet use are restraining the global market growth in the forecast period.

COVID-19 Impact.

During the COVID-19 pandemic, the constraint on socializing and social assemblages lessened the numeral of road traffic casualties, sports harms, and other medical ailments demanding surgical intervention, forcing a decline in the market growth globally. For example, according to the International Society of Aesthetic Plastic Surgery, plastic surgery procedures dropped during the pandemic. Approximately 10.9% and around 78% of surgeons experienced temporary practice closure. Furthermore, according to the national health institute, orthopedic surgery was down by about 23% during the first pandemic year. Among which orthopedic surgeries, knee arthroplasty had the utmost influence. It was down by almost 64%, pursued by hip arthroplasty and knee ligament reconstruction by about 41% and 44%, respectively, lessening the need for a tourniquet market. These statistics show that the tourniquet market was negatively impacted by the COVID-19 pandemic globally.

Segment Analysis

Tourniquet systems are expected to dominate the market throughout the forecast period (2022-2029).

The increasing access to specialty care products, pathological products, clinical examination, and diagnosis at a single premise is best possible in hospitals, indicating an exponential segment growth. Hospitals are the major end-user facilities for tourniquets. Moreover, the increasing numeral of sports-related injuries and road casualties raises the number of orthopedic cases, thereby driving the need for hospital-related cases. According to the National Safety Council (NSC), over 55.4 million injuries were experienced in the United States, a 15.7% increase from 2019 to 2020. The Bureau of Labor Statistics (BLS) reports that private industry employers registered over 2.7 million nonfatal workplace injuries and illnesses in 2020. The preventable injuries in the home in 2020 were about 31,800,000 means that one person in 10 in the U.S. encountered a medically consulted injury. Likewise, bicycling accounted for about 426,000 injuries in 2020. According to the National Center for Health Statistics, part of the Centers for Disease Control and Prevention, hospital emergency rooms across the country receive over 145.6 million patients annually.

Old people are more susceptible to orthopedic disorders. According to the World Population Aging globally, there were 727 million persons aged 65 years or over in 2020. Since women live longer than men, they comprise the majority of older persons, especially at advanced ages. This rise in life expectancies and age-related comorbidities results in the growth of geriatric orthopedic surgical procedures. Additionally, the central government offers partial or complete coverage for in-home services in most developed and developing nations. In the U.S., Medicare reimbursements are highly favorable in providing value-based healthcare for improved patient outcomes at a low cost. Thus, from the mentioned data, it is estimated that the hospital end user will dominate the global tourniquet market throughout the forecast period.

Geographical Analysis

The North American region holds the largest global Tourniquet market share.

North American tourniquets market will grow at high CAGR throughout the forecast period (2022-2029). According to the International Society of Aesthetic Plastic Surgery, the U.S. had an immense number of surgeons, with over 7,000 plastic surgeons in 2020, conducted across 3,182,815 non-surgical procedures and approximately 1,485,116 Surgical practices. Again, according to the same survey, the total number of operations executed in Mexico was over 860,718 in 2020. Likewise, from the data obtained by the U.S. Department of transportation`s fatality analysis reporting system, approximately 35,766 fatal vehicle crashes occurred in the U.S. in 2020, inducing roughly 38,824 deaths.

Additionally, there are presently nearly 18,380 orthopedic surgeons in America practicing, indicating that North America maintains a major market share. Another reason North America owns a significant market share is the risen prevalence of obesity. For example, according to the National data from the 2017-2020 National Health and Nutrition Examination Survey, more than 41.9% of adults are obese. Therefore, from about mentioned data, it is predicted that North America will dominate the global Tourniquet Market during the forecast period (2022-2029).

Competitive Landscape

The tourniquet market is moderately competitive due to the presence of key local and global players. Some key players are Zimmer Biomet, Stryker, ATMOS MedizinTechnik GmbH & Co. KG, VBM, DDM, Anetic Aid, HPM, Huifeng Medical, DS MAREF, and Bohua Medical. These key players hold the major share of the market through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in May 2021, ATMOS MedizinTechnik GmbH & Co. KG acquired the tourniquets device portfolio of Ulrich medical.

Zimmer Biomet

Overview:

Zimmer Biomet was in 1927 and has operations in more than 25 countries around the world and more than 100 countries to sell their product with a vast portfolio. Also, it is a leading company focusing on alleviating pain and improving the quality of life for people around the world.

Product Portfolio:

Zimmer Biomet's tourniquet product portfolio has A.T.S. 5000 Tourniquet Systems: The A.T.S. 5000 combines Personalized Pressure Technology with the new customizable user choosing to deliver a personalized experience for patients and healthcare professionals without disrupting workflow.

The global tourniquet market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Number of Orthopedic and Plastic Surgeries
      • 4.1.1.2. Increasing Incidents of Road Accidents
    • 4.1.2. Restraints
      • 4.1.2.1. Tourniquet Injuries
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 7.1.2. Market Attractiveness Index, By Component
  • 7.2. Tourniquet Instrument
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Tourniquet cuffs
    • 7.3.1. Pneumatic Tourniquet Cuffs*
    • 7.3.2. Non-Pneumatic Tourniquet Cuffs

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Upper-Limb Surgery
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Lower-Limb Surgery
  • 8.4. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals & Clinics
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Ambulatory Surgery Centers
  • 9.4. Orthopedic Clinics

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Company Profiles

  • 12.1. Zimmer Biomet
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Stryker
  • 12.3. ATMOS MedizinTechnik GmbH & Co. KG
  • 12.4. VBM
  • 12.5. DDM
  • 12.6. Anetic Aid
  • 12.7. HPM
  • 12.8. Huifeng Medical
  • 12.9. DS MAREF
  • 12.10. Bohus Medical

LIST NOT EXHAUSTIVE

13. DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us